Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Jordi Llaudó"'
Autor:
Christoph U. Correll, Robert E. Litman, Yuriy Filts, Jordi Llaudó, Dieter Naber, Ferran Torres, Javier Martínez
Publikováno v:
npj Schizophrenia, Vol 6, Iss 1, Pp 1-9 (2020)
Abstract To evaluate the efficacy and safety of Risperidone ISM® against placebo in patients with acute exacerbation of schizophrenia. A multicenter, randomized, double-blind, placebo-controlled study was conducted between June 2017 and December 201
Externí odkaz:
https://doaj.org/article/485f9847ecae4df6ad9a103f3ac27f37
Autor:
Jordi Llaudó Garín, Mayte Monreal, Javier Martínez González, Lourdes Ochoa Díaz de Monasterioguren, Ibón Gutierro Adúriz, Ignacio Ayani Almagia
Publikováno v:
Drug Design, Development and Therapy. 12:575-582
Purpose To demonstrate the pharmacokinetic/pharmacodynamic (PK/PD) equivalence of a biosimilar enoxaparin to the reference drug, and to assess its safety and tolerability in healthy volunteers. Patients and methods A randomized, double-blind, crossov
Autor:
Javier, Martínez González, Mayte, Monreal, Ignacio, Ayani Almagia, Jordi, Llaudó Garín, Lourdes, Ochoa Díaz de Monasterioguren, Ibón, Gutierro Adúriz
Publikováno v:
Drug Design, Development and Therapy
Purpose To demonstrate the pharmacokinetic/pharmacodynamic (PK/PD) equivalence of a biosimilar enoxaparin to the reference drug, and to assess its safety and tolerability in healthy volunteers. Patients and methods A randomized, double-blind, crossov
Autor:
González, Javier Martínez, Monreal, Mayte, Almagia, Ignacio Ayani, Garín, Jordi Llaudó, Monasterioguren, Lourdes Ochoa Díaz de, Adúriz, Ibón Gutierro
Publikováno v:
Drug Design, Development & Therapy; 2018, Vol. 12, p575-582, 8p
Autor:
Ibon Gutierro, Jordi Llaudó, Lourdes Anta, Mikhail Ivanov, Javier Martínez, Margarita Morozova, Ignacio Ayani, Juan Schronen
Publikováno v:
International clinical psychopharmacology. 31(6)
The aim of this study was to characterize the pharmacokinetics and to evaluate the safety of risperidone ISM in patients with schizophrenia or schizoaffective disorder after a single gluteal intramuscular injection at three different dose strengths (
Autor:
Litman, Robert, Naber, Dieter, Anta, Lourdes, Martínez, Javier, Filts, Yuriy, Correll, Christoph U
Publikováno v:
Neuropsychiatric Disease & Treatment; Jan2023, Vol. 19, p219-232, 14p
Autor:
Walling, David P, Hassman, Howard A, Anta, Lourdes, Ochoa, Lourdes, Ayani, Ignacio, Martínez, Javier, Gutierro, Ibon
Publikováno v:
Drug Design, Development & Therapy; Oct2021, Vol. 15, p4371-4382, 12p
Autor:
Martínez González J, Monreal M, Ayani Almagia I, Llaudó Garín J, Ochoa Díaz de Monasterioguren L, Gutierro Adúriz I
Publikováno v:
Drug Design, Development and Therapy, Vol Volume 12, Pp 575-582 (2018)
Javier Martínez González, Mayte Monreal, Ignacio Ayani Almagia, Jordi Llaudó Garín, Lourdes Ochoa Díaz de Monasterioguren, Ibón Gutierro Adúriz R&D Department, Laboratorios Farmacéuticos Rovi S.A., Madrid, Spain Purpose: To demonstrate the ph
Externí odkaz:
https://doaj.org/article/729d1077ba1d482f95dbbd0c6223486f
Autor:
Llaudó, Jordi, Anta, Lourdes, Ayani, Ignacio, Martínez, Javier, Schronen, Juan, Morozova, Margarita, Ivanov, Mikhail, Gutierro, Ibón
Publikováno v:
International Clinical Psychopharmacology; Nov2016, Vol. 31 Issue 6, p323-331, 9p
Autor:
MartÃnez González,Javier, Monreal Núñez,Mayte, Ayani Almagia,Ignacio, Llaudó GarÃn,Jordi, Ochoa DÃaz de Monasterioguren,Lourdes, Gutierro Adúriz,Ibón
Publikováno v:
Drug Design, Development and Therapy.
Javier Martínez González, Mayte Monreal, Ignacio Ayani Almagia, Jordi Llaudó Garín, Lourdes Ochoa Díaz de Monasterioguren, Ibón Gutierro Adúriz R&D Department, Laboratorios Farmacéuticos Rovi S.A., Madrid, Spain Purpose: To demonstrate the ph